
Bridget E. Bunner
Examiner (ID: 13118, Phone: (571)272-0881 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647, 1644 |
| Total Applications | 1451 |
| Issued Applications | 718 |
| Pending Applications | 165 |
| Abandoned Applications | 598 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5794259
[patent_doc_number] => 20060014940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Cloning and characterization of slc26a6, slc26a1, and slc26a2 anion exchangers'
[patent_app_type] => utility
[patent_app_number] => 10/505263
[patent_app_country] => US
[patent_app_date] => 2003-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 35364
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014940.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505263
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505263 | Cloning and characterization of slc26a6, slc26a1, and slc26a2 anion exchangers | Feb 27, 2003 | Abandoned |
Array
(
[id] => 6843168
[patent_doc_number] => 20030148515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Generation of hematopoietic cells from multipotent neutral stem cells'
[patent_app_type] => new
[patent_app_number] => 10/371779
[patent_app_country] => US
[patent_app_date] => 2003-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9975
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148515.pdf
[firstpage_image] =>[orig_patent_app_number] => 10371779
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/371779 | Generation of hematopoietic cells from multipotent neural stem cells | Feb 20, 2003 | Issued |
Array
(
[id] => 6740342
[patent_doc_number] => 20030157711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'STAT3 activated stem cell'
[patent_app_type] => new
[patent_app_number] => 10/369053
[patent_app_country] => US
[patent_app_date] => 2003-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11044
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10369053
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/369053 | STAT3 activated stem cell | Feb 17, 2003 | Issued |
Array
(
[id] => 6843019
[patent_doc_number] => 20030148366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins,and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/365646
[patent_app_country] => US
[patent_app_date] => 2003-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 23448
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148366.pdf
[firstpage_image] =>[orig_patent_app_number] => 10365646
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/365646 | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins,and uses thereof | Feb 12, 2003 | Abandoned |
Array
(
[id] => 6706770
[patent_doc_number] => 20030153504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'IL-16 antagonist peptides and DNA encoding the peptides'
[patent_app_type] => new
[patent_app_number] => 10/358627
[patent_app_country] => US
[patent_app_date] => 2003-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9066
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153504.pdf
[firstpage_image] =>[orig_patent_app_number] => 10358627
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/358627 | IL-16 antagonist peptides and DNA encoding the peptides | Feb 4, 2003 | Issued |
Array
(
[id] => 7318905
[patent_doc_number] => 20040224911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Transporters and ion channels'
[patent_app_type] => new
[patent_app_number] => 10/343903
[patent_app_country] => US
[patent_app_date] => 2003-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49094
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224911.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343903
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343903 | Transporters and ion channels | Feb 2, 2003 | Abandoned |
Array
(
[id] => 7336717
[patent_doc_number] => 20040132646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Identification of a novel glutamine transporter'
[patent_app_type] => new
[patent_app_number] => 10/343116
[patent_app_country] => US
[patent_app_date] => 2003-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9166
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132646.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343116
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343116 | Identification of a novel glutamine transporter | Jan 27, 2003 | Abandoned |
Array
(
[id] => 616320
[patent_doc_number] => 07144731
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-05
[patent_title] => 'SCF antibody compositions and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 10/353783
[patent_app_country] => US
[patent_app_date] => 2003-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 119
[patent_figures_cnt] => 98
[patent_no_of_words] => 52598
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/144/07144731.pdf
[firstpage_image] =>[orig_patent_app_number] => 10353783
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/353783 | SCF antibody compositions and methods of using the same | Jan 27, 2003 | Issued |
Array
(
[id] => 719675
[patent_doc_number] => 07049138
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => 'Epitope-tagged beta-amyloid precursor protein and DNA encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/326049
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 8796
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/049/07049138.pdf
[firstpage_image] =>[orig_patent_app_number] => 10326049
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/326049 | Epitope-tagged beta-amyloid precursor protein and DNA encoding the same | Dec 19, 2002 | Issued |
Array
(
[id] => 6821613
[patent_doc_number] => 20030219774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Novel human neurotransmitter transporter'
[patent_app_type] => new
[patent_app_number] => 10/319315
[patent_app_country] => US
[patent_app_date] => 2002-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 62104
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219774.pdf
[firstpage_image] =>[orig_patent_app_number] => 10319315
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/319315 | Novel human neurotransmitter transporter | Dec 12, 2002 | Abandoned |
Array
(
[id] => 6730680
[patent_doc_number] => 20030186870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders'
[patent_app_type] => new
[patent_app_number] => 10/315445
[patent_app_country] => US
[patent_app_date] => 2002-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7011
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186870.pdf
[firstpage_image] =>[orig_patent_app_number] => 10315445
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/315445 | Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders | Dec 9, 2002 | Abandoned |
Array
(
[id] => 7432219
[patent_doc_number] => 20040002079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness'
[patent_app_type] => new
[patent_app_number] => 10/314790
[patent_app_country] => US
[patent_app_date] => 2002-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8895
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20040002079.pdf
[firstpage_image] =>[orig_patent_app_number] => 10314790
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/314790 | Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness | Dec 8, 2002 | Abandoned |
Array
(
[id] => 7361691
[patent_doc_number] => 20040091453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Pancreatic langerhans beta cell proliferation promoter and apoptosis inhibitor, and screening of candidate compounds for the e drugs'
[patent_app_type] => new
[patent_app_number] => 10/297058
[patent_app_country] => US
[patent_app_date] => 2002-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13810
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20040091453.pdf
[firstpage_image] =>[orig_patent_app_number] => 10297058
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/297058 | Pancreatic langerhans beta cell proliferation promoter and apoptosis inhibitor, and screening of candidate compounds for the e drugs | Dec 1, 2002 | Abandoned |
Array
(
[id] => 6870050
[patent_doc_number] => 20030082739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/300827
[patent_app_country] => US
[patent_app_date] => 2002-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 68
[patent_no_of_words] => 23795
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082739.pdf
[firstpage_image] =>[orig_patent_app_number] => 10300827
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/300827 | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | Nov 20, 2002 | Abandoned |
Array
(
[id] => 7166667
[patent_doc_number] => 20040077041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Regulation of human follicle stimulating hormone-like g protein -coupled receptor'
[patent_app_type] => new
[patent_app_number] => 10/276550
[patent_app_country] => US
[patent_app_date] => 2002-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22942
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077041.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276550
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276550 | Regulation of human follicle stimulating hormone-like g protein -coupled receptor | Nov 17, 2002 | Abandoned |
Array
(
[id] => 6653091
[patent_doc_number] => 20030105303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Isolated mammalian monocyte cell genes; related reagents'
[patent_app_type] => new
[patent_app_number] => 10/290631
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30663
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105303.pdf
[firstpage_image] =>[orig_patent_app_number] => 10290631
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/290631 | Isolated mammalian monocyte cell genes; related reagents | Nov 7, 2002 | Abandoned |
Array
(
[id] => 330345
[patent_doc_number] => 07510840
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-03-31
[patent_title] => 'Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody'
[patent_app_type] => utility
[patent_app_number] => 10/280711
[patent_app_country] => US
[patent_app_date] => 2002-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 45
[patent_no_of_words] => 98223
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/510/07510840.pdf
[firstpage_image] =>[orig_patent_app_number] => 10280711
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/280711 | Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody | Oct 24, 2002 | Issued |
Array
(
[id] => 6856166
[patent_doc_number] => 20030129667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Method of diagnosing transmissible spongiform encephalopathies'
[patent_app_type] => new
[patent_app_number] => 10/278314
[patent_app_country] => US
[patent_app_date] => 2002-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6869
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129667.pdf
[firstpage_image] =>[orig_patent_app_number] => 10278314
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/278314 | Method of diagnosing transmissible spongiform encephalopathies | Oct 22, 2002 | Abandoned |
Array
(
[id] => 6796335
[patent_doc_number] => 20030175208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Neutrokine-alpha and neutrokine-alpha splice variant'
[patent_app_type] => new
[patent_app_number] => 10/270487
[patent_app_country] => US
[patent_app_date] => 2002-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 189408
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175208.pdf
[firstpage_image] =>[orig_patent_app_number] => 10270487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/270487 | Neutrokine-alpha and neutrokine-alpha splice variant | Oct 15, 2002 | Abandoned |
Array
(
[id] => 6815128
[patent_doc_number] => 20030074678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/270336
[patent_app_country] => US
[patent_app_date] => 2002-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 24125
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20030074678.pdf
[firstpage_image] =>[orig_patent_app_number] => 10270336
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/270336 | Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof | Oct 14, 2002 | Abandoned |